Matthew B. Klein - 21 May 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: Director
Issuer ticker: CLPT
Reported as of: 21 May 2026
Net transaction value: -$185,440
SEC form: 4
Accepted by SEC: 26 May 2026, 16:30:13 UTC
Prior SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Danilo D'Alessandro, by Power of Attorney for Matthew B. Klein

Key filing fact

Matthew B. Klein filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 26 May 2026.

Key facts

This page summarizes Matthew B. Klein's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 26 May 2026, 16:30.

Change

Previous filing in this sequence was filed on 21 May 2026.
Current net transaction value: -$185,440.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001808968 Primary reporting owner

Klein Matthew B.

Relationship: Director
Address: C/O CLEARPOINT NEURO, INC, 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature: /s/ Danilo D'Alessandro, by Power of Attorney for Matthew B. Klein
Signature date: 26 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Sale

Transaction value: $185,440
Shares: -16,000
Change %: -25%
Price: $11.59
Shares after: 46,935
Date: 21 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +12,820
Change %
Price: $0.000000^*
Shares after: 12,820
Date: 21 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,820
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a weighted average sales price per share. The shares were sold at prices ranging from $11.57 to $11.65. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

Footnote F3

The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.